Thursday, May 21, 2026
Today's Print

Tag: Anzu Partners

Filipino-led Intervenn Biosciences raises more than P2 billion to aid in ovarian cancer research and immuno-oncology

InterVenn Biosciences announced it has raised US$34 million in Series B fundraising -- translating to more than P2 billion -- for the biotech company...
- Advertisement -spot_img
- Advertisement -spot_img